<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>HIV cardiovascular health trials &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/hiv-cardiovascular-health-trials/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 02 Oct 2025 12:27:17 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>HIV cardiovascular health trials &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>The RESTART Trial Explores Drug Targeting Toxic HIV Protein</title>
		<link>https://bioengineer.org/the-restart-trial-explores-drug-targeting-toxic-hiv-protein/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 02 Oct 2025 12:26:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antibody-mediated immune depletion in HIV]]></category>
		<category><![CDATA[CD4+ T cell depletion]]></category>
		<category><![CDATA[gp120 neutralization strategies]]></category>
		<category><![CDATA[HIV cardiovascular health trials]]></category>
		<category><![CDATA[HIV gp120 glycoprotein]]></category>
		<category><![CDATA[HIV-associated chronic inflammation]]></category>
		<category><![CDATA[HIV-related comorbidities]]></category>
		<category><![CDATA[immune reconstitution therapy]]></category>
		<category><![CDATA[immune restoration therapy]]></category>
		<category><![CDATA[RESTART clinical trial]]></category>
		<guid isPermaLink="false">https://bioengineer.org/the-restart-trial-explores-drug-targeting-toxic-hiv-protein/</guid>

					<description><![CDATA[What if the secret to why some people living with HIV fail to fully recover their health, despite effective antiretroviral therapy, lies hidden in a little-understood viral protein? This provocative question has driven researchers at the University of Montreal’s CRCHUM to embark on an ambitious new clinical trial set to launch this fall, aiming to [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">275039</post-id>	</item>
	</channel>
</rss>
